Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco, GSK Reach Formulary Agreement For Medicare Part D

This article was originally published in The Pink Sheet Daily

Executive Summary

Medco describes the agreement as an "innovative collaboration" in a press release. Under the deal, Medco and GSK will share responsibility for providing access to and ensuring appropriate use of the products, the PBM said.

You may also be interested in...



Medco Reaches Risk-Sharing Rebate Agreements For 75% Of Part D Spend

The PBM is "very comfortable" that its rebating model is not outside of legal safe harbors, CEO Snow says. Under such formulary agreements, Medco receives incremental rebates when utilization exceeds set levels within a therapeutic category.

Medco Reaches Risk-Sharing Rebate Agreements For 75% Of Part D Spend

The PBM is "very comfortable" that its rebating model is not outside of legal safe harbors, CEO Snow says. Under such formulary agreements, Medco receives incremental rebates when utilization exceeds set levels within a therapeutic category.

GSK Does Not Expect Overly Restrictive Formularies Under Part D

GlaxoSmithKline does not expect formularies under the Medicare Part D drug benefit program to be overly restrictive

Related Content

Topics

UsernamePublicRestriction

Register

PS061807

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel